Notice of extraordinary general meeting of Medivir AB (publ)
News provided by
Share this article
Share this article
HUDDINGE, Sweden, Dec. 11, 2020 /PRNewswire/ The shareholders of Medivir AB, reg. no. 556238-4361, with its registered office in Huddinge, Stockholm, are hereby summoned to the extraordinary general meeting on Wednesday 13 January 2021.
In order to mitigate the spread of COVID-19, the board of directors has decided that the extraordinary general meeting will be conducted by advance voting only, without physical presence of shareholders, proxies and third parties.
Medivir welcomes all shareholders to exercise their voting rights at this extraordinary general meeting through advance voting on the basis of temporary statutory rules, according to the procedure set out below. Information on the resolutions passed at the extraordinary general meeting will be published on 13 January 2021, as soon as the result of the voting has been finally confirmed.